China Jo-Jo Drugstores, Inc. (CJJD)
NASDAQ: CJJD · Real-Time Price · USD
1.380
+0.030 (2.22%)
At close: Feb 21, 2025, 4:00 PM
1.360
-0.020 (-1.45%)
After-hours: Feb 21, 2025, 5:02 PM EST
China Jo-Jo Drugstores Revenue
China Jo-Jo Drugstores had revenue of $71.16M in the half year ending September 30, 2024, a decrease of -2.15%. This brings the company's revenue in the last twelve months to $147.13M, down -4.87% year-over-year. In the fiscal year ending March 31, 2024, China Jo-Jo Drugstores had annual revenue of $154.54M with 3.85% growth.
Revenue (ttm)
$147.13M
Revenue Growth
-4.87%
P/S Ratio
0.03
Revenue / Employee
$146,686
Employees
1,003
Market Cap
8.53M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 154.54M | 5.73M | 3.85% |
Mar 31, 2023 | 148.81M | -15.58M | -9.48% |
Mar 31, 2022 | 164.39M | 31.26M | 23.48% |
Mar 31, 2021 | 133.13M | 15.81M | 13.47% |
Mar 31, 2020 | 117.33M | 9.78M | 9.09% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
CJJD News
- 19 days ago - China Jo-Jo Drugstores Announces Strategic Business Restructuring to Strengthen Wholesale Business for Greater Profitability and Growth - PRNewsWire
- 7 months ago - China Jo-Jo Drugstores Reports Fiscal Year 2024 Financial Results - PRNewsWire
- 9 months ago - China Jo-Jo Drugstores Announces $3.37 Million Registered Direct Offering - PRNewsWire
- 9 months ago - China Jo-Jo Drugstores Announces Changes to Board of Directors - PRNewsWire
- 10 months ago - China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering - PRNewsWire
- 10 months ago - China Jo-Jo Drugstores Announces $1.53 Million Registered Direct Offering - PRNewsWire
- 1 year ago - China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 1 year ago - China Jo-Jo Drugstores, Inc. Announces 1-for-20 Reverse Stock Split - PRNewsWire